ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

Also: CALGB elects Schilsky to third term as chairman.

July 16, 2004

Organ Systems Program Adds Workshops On Lung, Colorectal Cancer

January 26, 1990

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade

August 9, 2013

ProPAC Calls For Adjustments In For Tobacco Advertising Ban

July 25, 1986

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989